171 related articles for article (PubMed ID: 31697836)
1. Bioengineered iPSC-derived megakaryocytes for the detection of platelet-specific patient alloantibodies.
Zhang N; Santoso S; Aster RH; Curtis BR; Newman PJ
Blood; 2019 Nov; 134(22):e1-e8. PubMed ID: 31697836
[TBL] [Abstract][Full Text] [Related]
2. O-linked sialic acid residues on platelet membrane glycoprotein IIb mask the human HPA-9b alloepitope.
Zhang N; Sullivan MJ; Curtis BR; Newman PJ
Blood; 2023 Nov; 142(22):1909-1917. PubMed ID: 37738558
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of HPA-3 alloantibodies: consequences for the diagnosis of alloimmune thrombocytopenic syndromes.
Socher I; Zwingel C; Santoso S; Kroll H
Transfusion; 2008 Mar; 48(3):463-72. PubMed ID: 18067506
[TBL] [Abstract][Full Text] [Related]
4. Severe neonatal alloimmune thrombocytopenia caused by antibodies to human platelet antigen 3a (Baka) detectable only in whole platelet assays.
Harrison CR; Curtis BR; McFarland JG; Huff RW; Aster RH
Transfusion; 2003 Oct; 43(10):1398-402. PubMed ID: 14507271
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes.
Zhang N; Zhi H; Curtis BR; Rao S; Jobaliya C; Poncz M; French DL; Newman PJ
Blood; 2016 Feb; 127(6):675-80. PubMed ID: 26634302
[TBL] [Abstract][Full Text] [Related]
6. Rapid detection of HPA-1 alloantibodies by platelet antigens immobilized onto microbeads.
Bakchoul T; Meyer O; Agaylan A; Bombard S; Bein G; Sachs UJ; Salama A; Santoso S
Transfusion; 2007 Aug; 47(8):1363-8. PubMed ID: 17655579
[TBL] [Abstract][Full Text] [Related]
7. Platelet alloantibodies in transfused patients.
Kiefel V; König C; Kroll H; Santoso S
Transfusion; 2001 Jun; 41(6):766-70. PubMed ID: 11399817
[TBL] [Abstract][Full Text] [Related]
8. Post-transfusion purpura (PTP) associated with anti-HPA-1a, anti-HPA-2b and anti-HPA-3a antibodies.
Lucas GF; Pittman SJ; Davies S; Solanki T; Brüggemann K
Transfus Med; 1997 Dec; 7(4):295-9. PubMed ID: 9510928
[TBL] [Abstract][Full Text] [Related]
9. Evidence of heterogeneity in the antibody response against the platelet antigen 3a; recognition of an 11-mer peptide carrying the HPA-3a polymorphic determinant.
de Leon EJ; Yuan FF; Pearson H; Marquis CP; Mahler SM
Vox Sang; 2009 Apr; 96(3):252-5. PubMed ID: 19159419
[TBL] [Abstract][Full Text] [Related]
10. Alloantibodies to human platelet glycoprotein antigens (HPA) and HLA class 1 in a cross section of Nigerian antenatal women.
Jeremiah ZA; Atiegoba AI; Mgbere O
Hum Antibodies; 2011; 20(3-4):71-5. PubMed ID: 22129676
[TBL] [Abstract][Full Text] [Related]
11. Alloimmune neonatal neutropenia and thrombocytopenia associated with maternal anti HNA-1a, HPA-3b and HLA antibodies.
Marín L; Torío A; Muro M; Fernandez-Parra R; Minguela A; Bosch V; Alvarez-López MR; García-Alonso AM
Pediatr Allergy Immunol; 2005 May; 16(3):279-82. PubMed ID: 15853961
[TBL] [Abstract][Full Text] [Related]
12. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
[TBL] [Abstract][Full Text] [Related]
13. Functional heterogeneity of alloantibodies against the human platelet antigen (HPA)-1a.
Kroll H; Penke G; Santoso S
Thromb Haemost; 2005 Dec; 94(6):1224-9. PubMed ID: 16411398
[TBL] [Abstract][Full Text] [Related]
14. Platelet-specific alloantigens and antibodies in Tunisian women after three or more pregnancies.
Skouri H; Gandouz R; Kraiem I; Dridi H; Bibi M; Khairi H; Jemmali M; Bierling P
Transfus Med; 2009 Oct; 19(5):269-73. PubMed ID: 19747290
[TBL] [Abstract][Full Text] [Related]
15. Maternal alloimmunization against the rare platelet-specific antigen HPA-9b (Max a) is an important cause of neonatal alloimmune thrombocytopenia.
Peterson JA; Balthazor SM; Curtis BR; McFarland JG; Aster RH
Transfusion; 2005 Sep; 45(9):1487-95. PubMed ID: 16131382
[TBL] [Abstract][Full Text] [Related]
16. Maternal immunization to Gov system alloantigens on human platelets.
Bordin JO; Kelton JG; Warner MN; Smith JW; Denomme GA; Warkentin TE; McGrath K; Minchinton R; Hayward CP
Transfusion; 1997 Aug; 37(8):823-8. PubMed ID: 9280327
[TBL] [Abstract][Full Text] [Related]
17. Alloantibody against new platelet alloantigen (Lap(a)) on glycoprotein IIb is responsible for a case of fetal and neonatal alloimmune thrombocytopenia.
Wihadmadyatami H; Heidinger K; Röder L; Werth S; Giptner A; Hackstein H; Knorr M; Bein G; Sachs UJ; Santoso S
Transfusion; 2015 Dec; 55(12):2920-9. PubMed ID: 26388194
[TBL] [Abstract][Full Text] [Related]
18. Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia.
Davoren A; Curtis BR; Aster RH; McFarland JG
Transfusion; 2004 Aug; 44(8):1220-5. PubMed ID: 15265127
[TBL] [Abstract][Full Text] [Related]
19. [Demonstration of platelet-specific alloantibodies in HLA-sensitized hematologic oncologic patients].
Schnaidt M; Wernet D; Mayer G; Northoff H
Beitr Infusionsther Transfusionsmed; 1994; 32():240-3. PubMed ID: 9480099
[TBL] [Abstract][Full Text] [Related]
20. Collaborative studies to establish the first World Health Organization International Standard for detection of human antibody against human platelet antigen-3a.
Berry J; Allen D; Porcelijn L; de Haas M; Kekomaki R; Kaplan C; Ouwehand WH; Metcalfe P
Vox Sang; 2007 Nov; 93(4):309-15. PubMed ID: 18070275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
